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866-3 Computer Vision in Echocardiography: Observer- 
Independent, Autonomous Echo Analysis Using 
Wavelet Footprints 
Christian H. Jansen, Muthuvel Arigovindan, Michael Siihling, Michael Unser, Stephan 
Marsch, Patrick Hunziker. University Hospital of Basel, Basel, Switzerland, Swiss 
Federal Institute of Technology, Lausanne, Switzerland 
Background: Echocardiography IS largely subjective with high observer dependence. 
Computer-assisted echo image analysis is demanding because of strong noise. absence 
of continuous boundaries and lack of constant intensities within objects. 
Method: Multidimensional multiscale wavelet analysis produces highly specific “foot- 
prints” from heart structures. We explolted this fact to create an automatic analysis enn- 
ronment that is based on shape and motion specific wavelet footprints of individual heart 
structures. TO test the feasibility of user-independent analysis, we applied the system for 
identification of the mitral valve autonomously in 182 echo loops. Gold standard for mitral 
valve location in the echo sequences was an experienced echocardiographer. 
Results: Autonomous analysis was successful in 165 of 182 ultrasound sequences COT- 
responding to 91% accuracy. The use of multidimensional multiscale footprints led to 
strong enhancement of the predefined structure (mitral valve, middle image) and signifi- 
cantly suppressed noise and non-related cardiac structures as shown in pixel statistics of 
the mitral valve region versus non related image parts (p < 0.05). yielding reliable auto- 
matic valve delineation (right image). 
Conclusion: Computer vision technology is applicable to clinical echo and allows 
obsenw-independent, automatic analysis of predefined cardiac structures, transforming 
the subjective and qualitative art of echo into a objective and quantitative science. 
866-4 Divx Compression Allows Medically Lossless lntranet 
or Internet Exchange of Coronary Angiograms 
Patrick Henry, Isaac Azancot, Lariboisiere, Paris, France 
Background: Coronary Angiograms (CA). even compressed, cannot be actually reason. 
ably sent via Internet networks due to their very large size. The aim of this study was to 
assess if DIVX compression can generate medically lossless dynamic sequences, and 
could permit the exchange of dynamic CA. 
Methods: We compared 30 random runs from 15 different CAlPTCAs by 13 independent 
blinded cardiologists. Two different DivX compression rates were analysed: the standard 
compression (StDivX) and an optimised compression (OpDivX) adapted for CA. For each 
run, the non compressed file (NCF) and each corresponding divX compressed file were 
simultaneously and randomly displayed on 2 identical monitors using the same video 
player. For each run the following score was gwen 0: no visual difference - 1: one 
screen aesthetically better - 2: small differences not clinically relevant - 3: differences 
eventually leading to misinterpretation - 4: major differences certainly leading to misinter- 
pretation. Results Compared to the non compressed files DtvX compressions induced a 
huge decrease in the file size of each run (mean size in MB: NCF: 55.2 - StDivX: 0.8 
OpDivX: 1.1). Table shows that the repartition of the scores between the corresponding 
390 NCF and DivX compressed video dynamic sequences was mainly 0 or 1 score with 
no 3 or 4 score for OpDivX. Conclusion : OpDivX compression is associated with a huge 
decrease in file size allowing IntraneVlntemet based video communication, while provid- 
ing medically lossless information. 
Standard DivX 
Optimized DivX 
DivX Better NCF Better 
4 3 2 1 0 1 2 3 4 
0% 0% 1% 7% 34% 44% 13% 1% 0% 
0% 0% 0% 10% 57% 31% 2% 0% 0% 
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871-l Modeling the Impact of Patient and Lesion 
Characteristics on the Cost-Effectiveness of Drug- 
Eluting Stents 
Dan Greenberg Ameet Bakhai, Nancy E. Neil, Ronna H. Berezin, Kalon K. Ho, Donald 
E. Cutlic. Richard E. Kuntz. David J. Cohen. Harvard Clinical Research Institute. Boston. 
MA, Be& Israel-Deaconess Medical Center; Boston, MA 
Drug-eluting stents (DES) are a promising technology for reducing restenosis after PCI. 
However, the cost-effectiveness (C/E) of these devices is unknown. Methods We used 
a decision-analytic model to project P-year costs and outcomes for patients undergoing 
single-vessel PCI, by either conventional stenting (CS) or DES. Angiographic restenosis 
rates with CS were estimated using a previously validated logistic regression model. 
Costs were assessed from a societal perspective. We assumed that 60% of patients with 
angiographic restenosis would require clinically driven target vessel revascularization 
and that DES would reduce restenosis rates by 90% at an incremental cost of $2,000/ 
stent. Results. C/E ratios were calculated as cost per repeat revascularization (RepRev) 
avoided and are displayed below (see Table). Compared with CS. DES was projected to 
have a C/E ratio < $10,000 per RepRev avoided (similar to other accepted PCI tech- 
niques) for patients with reference vessel diameters 4.0 mm and either lesion lengths 
215 mm 01 diabetes. DES was less attractive for patients with focal lesions in larger ves- 
sels (C/E ratio > $20,000 per RepRev avoided). Conclusions. At an incremental cost of 
$2,000 per stent, DES appears to be cost-effective for a large segment of patients under- 
going single vessel PCI. Lower incremental costs would render this technology cost say- 
ing for a wider target population. 
C/E ratio ($ per repeat revasculwization avoided) for diabetic and non-diabetlc patients 
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871-Z Safety of an Early Discharge Strategy Following 
Primary Intervention With Adjunctive Glycoprotein Ilbl 
llla inhibition: The CADILLAC Trial 
David E. Kandzari, James E. Tcheng, Cindy L. Grines, David J. Cohen, Ameet Bakhai. 
David A. Cox, Thomas D. Stuckey, Mark Effron. John J. Griffin, Mark Turco, John D. 
Carroll, Martin Fahy. Roxana Mehran. Gregg W. Stone, Duke Clinical Research Institute, 
Durham. NC, Cardiovascular Research Foundation. New York, NY 
Background- Early hospital discharge (D/C) following primaty percutaneous coronary 
intervention (PCI) for acute myocardial infarction (AMI) may be limited by early in-hospi- 
tal complications. Glycoprotein Ilb/llla inhibitors, by reducing early recurrent ischemia, 
may facilitate early D/C and reduce hospital costs. 
Methods- The CADILLAC trial randomized 2,082 patients (pts) with AMI to 1 of 4 reper- 
fusion strategies in a 2x2 factorial design: (1) PTCA (2) PTCA with abciximab (abcx), (3) 
stent implantation or (4) stenting with abcx. In pts randomized to abcx post procedural 
heparin was withheld, and D/C was scheduled on post Ml day 2 (low-risk patients) or 3 
(high-risk patients) if clinically stable. Patients not receiving abcx were discharged at the 
treatmg physician’s discretion. Early clinlcal outccmes and safety endpoints within 7 days 
following the index procedure were compared relative to treatment assignment and tim- 
ing of D/C. 
Results- Within the first 72 hours after pnmary PCI, abcx was associated with significant 
